Zenas BioPharma, Inc. Accounts Payable
Zenas BioPharma, Inc. (ZBIO) had Accounts Payable of $7.59 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable, Current $7.59M.
- 2026-03-31: Accounts Payable, Current $8.94M.
- 2025-12-31: Accounts Payable, Current $7.11M.
- 2025-09-30: Accounts Payable, Current $6.44M.
| Period end | Accounts Payable, Current |
|---|---|
| 2026-06-30 | $7.59M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $8.94M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $7.11M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $6.44M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $7.93M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $20.02M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $17.14M 10-K · filed 2026-03-16 |
| 2024-09-30 | $15.08M 10-Q · filed 2024-11-12 |
| 2023-12-31 | $5.40M 10-K · filed 2025-03-11 |